CD8A and breast carcinoma: Intra-tumoral CD8+ T-cell infiltration is associated with delayed recurrence and extended survival in patients [29], and infiltration of breast cancer with CD8+ cytotoxic T lymphocytes is associated with a good response to chemotherapy [30].